0
Orphan Designations
1
FDA Approvals
Latest: AVZIVI TNJN (2023)
0
Active Trials
200 recruiting
3
Rare Diseases
across 6 areas
0
News (30d)
Quiet
Bio-Thera Solutions, Ltd. is a company with 0 orphan drug designations across 3 rare diseases, including 1 FDA-approved therapy.
Disease-by-disease pipeline progression from orphan designation through clinical trials to FDA approval.
Source: FDA Orphan Drug Designations, ClinicalTrials.gov, Drugs@FDA
| Disease | Drug(s) | Stage |
|---|---|---|
| cervical cancer | AVZIVI TNJN | Des.TrialAppr. |
| colorectal cancer | AVZIVI TNJN | Des.TrialAppr. |
| renal cell carcinoma | AVZIVI TNJN | Des.TrialAppr. |
0% of portfolio targets high unmet need diseases
5
overlap in 2+ diseases
0/3
candidate diseases
0
avg importance: 0
0
affecting portfolio
0% of portfolio targets high unmet need diseases
5
overlap in 2+ diseases
0/3
candidate diseases
0
avg importance: 0
0
affecting portfolio